Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 145,887 | 37,142 | 39,165 | 95,088 | 41,259 |
| Marketable Securities | 26,268 | 39,487 | 46,208 | N/A | N/A |
| TOTAL | $175,755 | $78,117 | $85,996 | $96,371 | $42,446 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $175,755 | $78,117 | $85,996 | $96,371 | $42,446 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,828 | 3,536 | 1,775 | 2,265 | 3,801 |
| Accrued Expenses | 4,151 | 3,367 | 2,065 | 2,695 | 1,237 |
| TOTAL | $11,979 | $6,903 | $3,840 | $4,960 | $5,038 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $11,979 | $6,903 | $3,840 | $4,960 | $5,038 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,280 | 47,745 | 47,710 | 47,638 | 39,337 |
| Common Shares | 6 | 5 | 5 | 5 | 4 |
| Retained earnings | -113,765 | -91,643 | -79,061 | -68,521 | -58,752 |
| Other shareholders' equity | 98 | 210 | 0 | 0 | 0 |
| TOTAL | $163,776 | $71,214 | $82,156 | $91,411 | $37,408 |
| Total Liabilities And Equity | $175,755 | $78,117 | $85,996 | $96,371 | $42,446 |